Zymeworks Inc. (NYSE: ZYME) Files An 8-K Financial Statements and ExhibitsITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS
| † |
Confidential portions of this exhibit have been redacted and filed separately with the Securities and Exchange Commission to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. |
Zymeworks Inc. ExhibitEX-99.1 2 ex99-1.htm EXHIBIT 99.1 – LICENSE AND COLLABORATION AGREEMENT Exhibit 99.1 CONFIDENTIAL CONFIDENTIAL TREATMENT REQUESTED UNDER RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934,…To view the full exhibit click here
